Association of Time to Recurrence With Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Expression in Stage II and III Colorectal Cancer
- 14 May 2002
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 6 (3) , 331-337
- https://doi.org/10.1016/s1091-255x(02)00018-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy.International Journal of Oncology, 2000
- Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.2000
- Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical methodAnnals of Surgical Oncology, 2000
- Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patientsBritish Journal of Cancer, 2000
- Dihydropyrimidine dehydrogenase activity: prognostic partner of 5-fluorouracil?1999
- Colorectal cancerThe Lancet, 1999
- p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site.1998
- Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapyCancer Letters, 1997
- Simple technique for detecting RNA viruses by PCR in single sections of wax embedded tissue.Journal of Clinical Pathology, 1993
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974